In 2022, the selling and marketing expenses of Chinese pharmaceutical firm Innovent Biologics Inc. amounted to 2.58 billion yuan, increasing by 40 million from the year prior. The core products of Innovent Biologics include anti-tumor medicines and drugs treating metabolic disorders and autoimmune diseases.
Selling and marketing expenses of Innovent Biologics Inc. from 2019 to 2022
(in billion yuan)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Innovent Biologics. (March 28, 2023). Selling and marketing expenses of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1404933/chinese-pharmaceuticals-innovent-biologics-selling-and-marketing-expenses/
Innovent Biologics. "Selling and marketing expenses of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan)." Chart. March 28, 2023. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1404933/chinese-pharmaceuticals-innovent-biologics-selling-and-marketing-expenses/
Innovent Biologics. (2023). Selling and marketing expenses of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan). Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1404933/chinese-pharmaceuticals-innovent-biologics-selling-and-marketing-expenses/
Innovent Biologics. "Selling and Marketing Expenses of Innovent Biologics Inc. from 2019 to 2022 (in Billion Yuan)." Statista, Statista Inc., 28 Mar 2023, https://www.statista.com/statistics/1404933/chinese-pharmaceuticals-innovent-biologics-selling-and-marketing-expenses/
Innovent Biologics, Selling and marketing expenses of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) Statista, https://www.statista.com/statistics/1404933/chinese-pharmaceuticals-innovent-biologics-selling-and-marketing-expenses/ (last visited December 22, 2024)
Selling and marketing expenses of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) [Graph], Innovent Biologics, March 28, 2023. [Online]. Available: https://www.statista.com/statistics/1404933/chinese-pharmaceuticals-innovent-biologics-selling-and-marketing-expenses/
